Solving the Puzzle
of Lung Cancer Complexity
with Artificial Intelligence

What is I3LUNG

I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.

For Patients

In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).

We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)

Find out the most relevant news on the latest advancements in lung cancer!

World Cancer Day

Lungs don’t speak, but they tell a story. Every breath holds a secret of resilience, of science pushing forward, of […]

AI is not the future, it’s the present of lung cancer

On January 31st and February 1st, Dr. Arsela Prelaj, (PI) of the I3LUNG project, took the conversation to the next […]

The Patient’s Voice in the Digital Era: Yvonne Díaz, Advocate for Lung Cancer Europe, at Upsmart 2024

As part of the I3LUNG project, we highlight the inspiring presentation by Yvonne Díaz, patient advocate and member of Lung […]